vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Red Cat Holdings, Inc. (RCAT). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $8.1M, roughly 1.2× Arcellx, Inc.). Red Cat Holdings, Inc. runs the higher net margin — -166.0% vs -766.0%, a 600.0% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs -79.3%). Red Cat Holdings, Inc. produced more free cash flow last quarter ($-24.5M vs $-63.9M).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

ACLX vs RCAT — Head-to-Head

Bigger by revenue
RCAT
RCAT
1.2× larger
RCAT
$9.6M
$8.1M
ACLX
Growing faster (revenue YoY)
RCAT
RCAT
+1067.5% gap
RCAT
988.2%
-79.3%
ACLX
Higher net margin
RCAT
RCAT
600.0% more per $
RCAT
-166.0%
-766.0%
ACLX
More free cash flow
RCAT
RCAT
$39.4M more FCF
RCAT
$-24.5M
$-63.9M
ACLX

Income Statement — Q1 FY2025 vs Q3 FY2025

Metric
ACLX
ACLX
RCAT
RCAT
Revenue
$8.1M
$9.6M
Net Profit
$-62.3M
$-16.0M
Gross Margin
6.6%
Operating Margin
-847.6%
-181.7%
Net Margin
-766.0%
-166.0%
Revenue YoY
-79.3%
988.2%
Net Profit YoY
-765.1%
-29.0%
EPS (diluted)
$-1.13
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
RCAT
RCAT
Q3 25
$9.6M
Q1 25
$8.1M
$1.6M
Q4 24
$15.3M
$0
Q3 24
$26.0M
Q2 24
$27.4M
Q1 24
$39.3M
$5.8M
Q4 23
$63.1M
Q3 23
$15.0M
Net Profit
ACLX
ACLX
RCAT
RCAT
Q3 25
$-16.0M
Q1 25
$-62.3M
$-23.1M
Q4 24
$-47.1M
$-13.3M
Q3 24
$-25.9M
Q2 24
$-27.2M
Q1 24
$-7.2M
$-5.5M
Q4 23
$19.8M
Q3 23
$-39.3M
Gross Margin
ACLX
ACLX
RCAT
RCAT
Q3 25
6.6%
Q1 25
-52.2%
Q4 24
Q3 24
Q2 24
Q1 24
18.8%
Q4 23
Q3 23
Operating Margin
ACLX
ACLX
RCAT
RCAT
Q3 25
-181.7%
Q1 25
-847.6%
-765.7%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
-76.0%
Q4 23
23.8%
Q3 23
-299.9%
Net Margin
ACLX
ACLX
RCAT
RCAT
Q3 25
-166.0%
Q1 25
-766.0%
-1418.9%
Q4 24
-308.4%
Q3 24
-99.4%
Q2 24
-99.3%
Q1 24
-18.3%
-93.9%
Q4 23
31.4%
Q3 23
-263.0%
EPS (diluted)
ACLX
ACLX
RCAT
RCAT
Q3 25
$-0.16
Q1 25
$-1.13
$-0.27
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14
Q4 23
$0.42
Q3 23
$-0.81

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
RCAT
RCAT
Cash + ST InvestmentsLiquidity on hand
$543.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$253.3M
Total Assets
$648.1M
$286.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
RCAT
RCAT
Q3 25
Q1 25
$543.3M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Q4 23
$702.0M
Q3 23
$439.7M
Stockholders' Equity
ACLX
ACLX
RCAT
RCAT
Q3 25
$253.3M
Q1 25
$416.9M
$28.9M
Q4 24
$454.8M
$27.0M
Q3 24
$483.0M
Q2 24
$487.2M
Q1 24
$496.6M
$49.6M
Q4 23
$485.4M
Q3 23
$266.1M
Total Assets
ACLX
ACLX
RCAT
RCAT
Q3 25
$286.0M
Q1 25
$648.1M
$59.7M
Q4 24
$711.3M
$51.1M
Q3 24
$764.9M
Q2 24
$734.3M
Q1 24
$779.7M
$55.3M
Q4 23
$825.1M
Q3 23
$614.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
RCAT
RCAT
Operating Cash FlowLast quarter
$-63.1M
$-23.9M
Free Cash FlowOCF − Capex
$-63.9M
$-24.5M
FCF MarginFCF / Revenue
-786.4%
-254.2%
Capex IntensityCapex / Revenue
9.6%
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$-55.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
RCAT
RCAT
Q3 25
$-23.9M
Q1 25
$-63.1M
$-15.9M
Q4 24
$-46.0M
$-10.1M
Q3 24
$30.7M
Q2 24
$-36.2M
Q1 24
$-31.9M
$-4.1M
Q4 23
$58.2M
Q3 23
$-10.1M
Free Cash Flow
ACLX
ACLX
RCAT
RCAT
Q3 25
$-24.5M
Q1 25
$-63.9M
$-16.2M
Q4 24
$-47.5M
$-10.2M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
$-4.2M
Q4 23
$53.0M
Q3 23
$-18.0M
FCF Margin
ACLX
ACLX
RCAT
RCAT
Q3 25
-254.2%
Q1 25
-786.4%
-992.9%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
-71.1%
Q4 23
83.9%
Q3 23
-120.5%
Capex Intensity
ACLX
ACLX
RCAT
RCAT
Q3 25
6.9%
Q1 25
9.6%
16.8%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
0.8%
Q4 23
8.4%
Q3 23
53.0%
Cash Conversion
ACLX
ACLX
RCAT
RCAT
Q3 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
2.94×
Q3 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

Related Comparisons